These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 6343262

  • 1. Pirbuterol versus orciprenaline aerosols in the treatment of bronchial asthma.
    Beumer HM.
    Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):147-66. PubMed ID: 6343262
    [Abstract] [Full Text] [Related]

  • 2. Comparison of safety and efficacy of inhaled pirbuterol with metaproterenol.
    Tinkelman DG, Brandon ML, Grieco M, Hudson L, Rosenthal RR, Spector SL, Tashkin D, Votteri B.
    Ann Allergy; 1990 Feb; 64(2 Pt 2):202-6. PubMed ID: 2405746
    [Abstract] [Full Text] [Related]

  • 3. Long-term treatment of bronchial asthma with pirbuterol aerosol.
    Beumer HM.
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):172-5. PubMed ID: 6862719
    [Abstract] [Full Text] [Related]

  • 4. Comparative investigations on pirbuterol, salbutamol and placebo aerosols in bronchial asthma.
    Beumer HM.
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):237-9. PubMed ID: 381220
    [Abstract] [Full Text] [Related]

  • 5. [Pirbuterol and salbutamol aerosol for exercise-induced bronchoconstriction].
    Aebischer JC, Benoit RC, Scherrer M.
    Schweiz Med Wochenschr; 1984 Nov 17; 114(46):1660-4. PubMed ID: 6515368
    [Abstract] [Full Text] [Related]

  • 6. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
    Kuna P, Creemers JP, Vondra V, Black PN, Lindqvist A, Nihlen U, Vogelmeier C.
    Respir Med; 2006 Dec 17; 100(12):2151-9. PubMed ID: 16701989
    [Abstract] [Full Text] [Related]

  • 7. Acute bronchial and cardiovascular effects of oral pirbuterol and metaproterenol.
    Ence TJ, Tashkin DP, Ho D, Child JS.
    Ann Allergy; 1979 Oct 17; 43(4):229-36. PubMed ID: 555600
    [Abstract] [Full Text] [Related]

  • 8. [Double blind test with hexoprenaline (Ipradol)-dosage-aerosol apparatus in bronchial asthma].
    Dübi B, Studer A, Scherrer M.
    Schweiz Med Wochenschr; 1974 Jun 08; 104(23):827-31. PubMed ID: 4601410
    [No Abstract] [Full Text] [Related]

  • 9. Double-blind, crossover comparison of carbuterol and salbutamol.
    Guleria JS, Vasu KV, Pande JN.
    Ann Allergy; 1979 Aug 08; 43(2):123-5. PubMed ID: 380412
    [Abstract] [Full Text] [Related]

  • 10. A clinical trial of the bronchodilator effect of Sch 1000 aerosol in asthmatic children.
    Lin MT, Lee-Hong E, Collins-Williams C.
    Ann Allergy; 1978 May 08; 40(5):326-32. PubMed ID: 347990
    [Abstract] [Full Text] [Related]

  • 11. Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treating cough-variant asthma.
    Irwin RS, French CT, Smyrnios NA, Curley FJ.
    Arch Intern Med; 1997 Sep 22; 157(17):1981-7. PubMed ID: 9308510
    [Abstract] [Full Text] [Related]

  • 12. Pirbuterol in the treatment of bronchial asthma.
    Beumer HM.
    Int J Clin Pharmacol Biopharm; 1979 Jan 22; 17(1):18-25. PubMed ID: 367975
    [Abstract] [Full Text] [Related]

  • 13. [A combination of alupent and adumbran (Tranquo-alupent) for the treatment of the asthmatic syndrome. Single dose studies with pulmonary function tests in double blind technic].
    Günthner W.
    Med Klin; 1968 May 17; 63(20):795-7. PubMed ID: 4884224
    [No Abstract] [Full Text] [Related]

  • 14. The efficacy and safety of budesonide inhalation suspension: a nebulizable corticosteroid for persistent asthma in infants and young children.
    White MV, Cruz-Rivera M, Walton-Bowen K.
    Fam Med; 1999 May 17; 31(5):337-45. PubMed ID: 10407712
    [Abstract] [Full Text] [Related]

  • 15. Sixty day trial of a new inhalant dosage form of metaproterenol.
    Chervinsky P.
    Ann Allergy; 1977 Feb 17; 38(2):107-11. PubMed ID: 320913
    [Abstract] [Full Text] [Related]

  • 16. [Comparison of the effect of aerosol inhalation with Salbutamol and Trimetolquinol of four and a half minutes duration with that of Tacholiquin-Orciprenalin of fifteen minutes duration in bronchial asthma].
    Scherrer M, Bachofen H.
    Schweiz Med Wochenschr; 1972 Jul 01; 102(26):909-14. PubMed ID: 4556145
    [No Abstract] [Full Text] [Related]

  • 17. Pirbuterol vs. hydroxyzine vs. theophylline vs. placebo in the treatment of bronchial asthma.
    Brandon ML.
    Ann Allergy; 1980 Jul 01; 45(1):8-12. PubMed ID: 7406244
    [Abstract] [Full Text] [Related]

  • 18. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
    Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Taylor DR.
    Respir Med; 2000 Aug 01; 94(8):767-71. PubMed ID: 10955752
    [Abstract] [Full Text] [Related]

  • 19. A comparison between aerosol and inhaled powder administration of fenoterol in adult asthmatics.
    Harris R, Rothwell RP.
    N Z Med J; 1981 Dec 09; 94(697):421-2. PubMed ID: 7038565
    [Abstract] [Full Text] [Related]

  • 20. [Bronchospasmolytic effect of reproterol as aerosol (author's transl)].
    Voss H, Aurich R.
    Dtsch Med Wochenschr; 1979 Jul 20; 104(29):1041-3. PubMed ID: 380952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.